Be the first to like.

Share

During the most recent Ebola outbreak in West Africa, health-care workers treated some sick patients by injecting them with plasma—the translucent part of the blood—taken from individuals who had survived the disease. In the absence of an approved drug to treat patients, the hope was that protective proteins in the donor plasma would help recipients fight the disease and recover.

A biotech company wants to use this same approach to treat a variety of infectious diseases, with one key difference: cows, not humans, will be the plasma donors.

… Read More

Image: AttributionNoncommercialShare Alike Some rights reserved by The Kitten’s Toe

Be the first to like.

Share
MIT Technology Review

Tags: , , , , , , , ,

Leave a Reply